These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22014634)

  • 1. Sulodexide for diabetic nephropathy: another one bites the dust.
    House AA; Weir MA
    Am J Kidney Dis; 2011 Nov; 58(5):692-4. PubMed ID: 22014634
    [No Abstract]   [Full Text] [Related]  

  • 2. Discounting the efficacy of sulodexide in diabetic nephropathy is premature.
    Gambaro G
    Am J Kidney Dis; 2012 Jul; 60(1):169-70. PubMed ID: 22709598
    [No Abstract]   [Full Text] [Related]  

  • 3. Game not over for sulodexide.
    Coccheri S
    Am J Kidney Dis; 2012 Mar; 59(3):467. PubMed ID: 22340910
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
    Lewis EJ; Lewis JB; Greene T; Hunsicker LG; Berl T; Pohl MA; de Zeeuw D; Heerspink HL; Rohde RD; Atkins RC; Reutens AT; Packham DK; Raz I;
    Am J Kidney Dis; 2011 Nov; 58(5):729-36. PubMed ID: 21872376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate versus clinical end points and venture capital companies: the doubts of a clinician.
    Gaddi AV; Benedetto D
    Am J Kidney Dis; 2012 Jul; 60(1):170; author reply 170-1. PubMed ID: 22709600
    [No Abstract]   [Full Text] [Related]  

  • 6. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
    Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
    J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.
    Packham DK; Wolfe R; Reutens AT; Berl T; Heerspink HL; Rohde R; Ivory S; Lewis J; Raz I; Wiegmann TB; Chan JC; de Zeeuw D; Lewis EJ; Atkins RC;
    J Am Soc Nephrol; 2012 Jan; 23(1):123-30. PubMed ID: 22034636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
    Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
    Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
    Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.
    Li R; Xing J; Mu X; Wang H; Zhang L; Zhao Y; Zhang Y
    Drug Des Devel Ther; 2015; 9():6275-83. PubMed ID: 26664049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans as a possible tool for micro- and macroalbuminuria in diabetic patients. A pilot study.
    Sorrenti G; Grimaldi M; Canova N; Palazzini E; Melchionda N
    J Int Med Res; 1997; 25(2):81-6. PubMed ID: 9100162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
    Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
    Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy.
    Dedov I; Shestakova M; Vorontzov A; Palazzini E
    Nephrol Dial Transplant; 1997 Nov; 12(11):2295-300. PubMed ID: 9394314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finerenone for Albuminuria in Patients With Diabetic Nephropathy.
    Feng Y; Zeng X; Fu P
    JAMA; 2016 Jan; 315(3):305-6. PubMed ID: 26784783
    [No Abstract]   [Full Text] [Related]  

  • 17. Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
    Bakris GL; Nowack C
    JAMA; 2016 Jan; 315(3):306. PubMed ID: 26784785
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetic nephropathy: Nonsteroidal MRA added to RAS blockade reduces albuminuria.
    Weir MR
    Nat Rev Nephrol; 2015 Dec; 11(12):691-2. PubMed ID: 26460357
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetic patients have to be tested regularly for microalbuminuria. Almost every second one has already kidney damage].
    MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulodexide in the treatment of diabetic nephropathy].
    Rasovskiĭ BL; Tarasov AV; Trel'skaia NIu; Severina TI; Chernykh EF
    Klin Med (Mosk); 1998; 76(7):40-2. PubMed ID: 9742778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.